NAP

• Description:

  Davunetide is an eight amino acid peptide (NAPVSIPQ) with potent neuroprotection in vitro and in vivo. Davunetide has been shown to enhance functional daily behaviors in schizophrenia patients and to increase memory scores in patients suffering from amnestic mild cognitive impairment.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  824.94

• Molecular Formula:

  C36H60N10O12

• Notes:

  Research use only, not for human use.

• Receptor:

  Other Targets

• CAS Number:

  211439-12-2